IPO registrations (S-1, F-1) · Registrants
ZYMOGENETICS INC
- SEC CIK
- 1129425 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2001-09-10, last 2002-01-31; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2002-02-01
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- WA
- Business address
- 1201 EASTLAKE AVENUE E, Seattle, WA 98102
- EIN
- 91-1144498
- EDGAR entity type
- operating
- Insiders and CEO pay
- ZYMOGENETICS INC on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2002-01-31)
- Final price
- $12.00 per share, within the range (424B4 filed 2002-02-01, an initial public offering)
- Shares sold
- 10,000,000
- Gross proceeds
- $120,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ZGEN
- Lead underwriters
- Lehman Brothers; Merrill Lynch (3,132,500 shares); Bear Stearns (1,611,000 shares); Pacific Growth Equities, Inc (1,074,000 shares)
- Syndicate
- Cantor Fitzgerald (100,000); A.G. Edwards (100,000); McAdams Wright Ragen, Inc (100,000); Prudential Securities (100,000); Cowen (100,000); Wells Fargo (100,000); Brean Murray & Co., Inc (50,000); Chatsworth Securities LLC (50,000); Fahnestock & Co. Inc (50,000); Fortis Securities Inc (50,000); C.L. King & Associates (50,000); Leerink Partners (50,000); Utendahl Capital Partners, L.P (50,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ZYMOGENETICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: ZYMOGENETICS, INC. Fuzzy (name and state)
- Lobbying client: ZYMOGENETICS Fuzzy (name and state)
- SEC filer: ZYMOGENETICS INC EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2001-09-10 | S-1 | S-1 (registration) | ZYMOGENETICS INC | 0001032210-01-501085 ↗ |
| 2001-11-02 | S-1/A | S-1/A (amendment) | ZYMOGENETICS INC | 0001032210-01-501267 ↗ |
| 2002-01-10 | S-1/A | S-1/A (amendment) | ZYMOGENETICS INC | 0001032210-02-000018 ↗ |
| 2002-01-31 | S-1/A | S-1/A (amendment) | ZYMOGENETICS INC | 0001032210-02-000099 ↗ |
| 2002-02-01 | 424B4 | 424B4 (final prospectus) | ZYMOGENETICS INC | 0001032210-02-000106 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2002-01-31 | S-1/A | registration statement | $12.00–$14.00 | 10,000,000 | - | Nasdaq ZGEN | 5 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 5 | document ↗ | |
| 2002-02-01 | 424B4 | final prospectus | $12.00 | 10,000,000 | $120,000,000 | Nasdaq ZGEN | 17 | primary document; price sentence, shares headline, proceeds table, underwriting table 16, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| CARTER BRUCE L A | Director; Director,Officer; Officer | CEO & Chairman of the Board; President & CEO; President & CEO & Board Chair | 14 | 2006–2010 | |
| HENELL FREDRIK | Officer | Sr VP Business Development | 4 | 2006 | |
| JOHNSON JAMES A | Officer | Executive VP and CFO; Senior Vice President and CFO; Senior VP and CFO | 17 | 2006–2010 | |
| OHRSTROM JAN K | Officer | Sr. VP, Business Development; Sr. VP, Commercial Operations | 7 | 2006–2007 | |
| ONETTO NICOLE | Officer | Sr. VP & Chief Medical Officer | 5 | 2006–2009 | |
| SHEMA SUZANNE M | Officer | Senior VP, General Counsel; SVP Intellectual Prop. & Legal | 14 | 2006–2009 | |
| WILLIAMS DOUGLAS E | Director; Director,Officer; Officer | CEO; Chief Executive Officer; Executive VP R&D and CSO; President and CSO | 13 | 2006–2010 | |
| YOUNG MARK D | Officer | Sr VP, Technical Operations | 9 | 2006 | |
| HEMBERGER JUDITH A | Director | 5 | 2006–2009 | ||
| Dwyer Michael J | Officer | Senior VP, Marketing and Sales; Senior VP, Marketing & Sales | 6 | 2006–2009 | |
| HIMES VAUGHN B | Officer | Sr. VP, Technical Operation; SR VP, Technical Operations | 6 | 2006–2009 | |
| Harper James A | Director | 7 | 2006–2010 | ||
| HIRSH DAVID I | Director | 6 | 2006–2010 | ||
| LEFF JONATHAN S | Director; Director,TenPercentOwner | 14 | 2006–2010 | ||
| MacCallum David | Director | 7 | 2006–2010 | ||
| NIELSEN KURT ANKER | Director | 7 | 2006–2010 | ||
| PENHOET EDWARD | Director | 7 | 2006–2010 | ||
| SORENSEN LARS REBIEN | Director | 4 | 2006–2009 | ||
| Hamby Darren R | Officer | Sr. VP, HR & Corp Svcs; Sr. VP, Human Resources | 10 | 2007–2010 | |
| KAYE CHARLES R | TenPercentOwner | 9 | 2007–2010 | ||
| LANDY JOSEPH | TenPercentOwner | 9 | 2007–2010 | ||
| WARBURG PINCUS & CO | TenPercentOwner | 9 | 2007–2010 | ||
| WARBURG PINCUS EQUITY PARTNERS LP | TenPercentOwner | 9 | 2007–2010 | ||
| WARBURG PINCUS LLC | TenPercentOwner | 9 | 2007–2010 | ||
| Warburg Pincus Partners LLC | TenPercentOwner | 9 | 2007–2010 | ||
| Franklin Heather L | Officer | Sr. VP, Business Development | 6 | 2008–2010 | |
| Zaruby Stephen W | Officer | President | 5 | 2009–2010 | |
| Ramos Eleanor | Officer | Sr. VP, Chief Medical Officer | 5 | 2009–2010 | |
| Miller Dennis M. | Officer | Sr VP, Resrch & Preclin Devl | 6 | 2009–2010 | |
| NOVO NORDISK A S | Other; TenPercentOwner | 2 | 2010 | ||
| Montgomery Alan Bruce | Director | 2 | 2010 | ||
| Jorgensen Lars Fruergaard | Director | 3 | 2010 | ||
| BRISTOL MYERS SQUIBB CO | TenPercentOwner | 2 | 2010 | ||
| Zeus Acquisition Corp | TenPercentOwner | 2 | 2010 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | ZYMOGENETICS, INC | WA | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | ZYMOGENETICS, INC. | WA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | ZYMOGENETICS, INC. | WA | Federal spending (USAspending) | name and state |
| Lobbying client | ZYMOGENETICS | WA | Federal lobbying (LDA) | name and state |
| Nonprofit | TOASTMASTERS INTERNATIONAL | WA | Nonprofits (IRS Form 990) | same street address and ZIP code, 1201 EASTLAKE AVE E 98102 (FUZZY: a shared address, not proof of a shared organization) |
| Patent assignee | ZYMOGENETICS INC. | WA | Patents (USPTO) | name and state |
| SEC filer | ZYMOGENETICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | ZymoGenetics, Inc. | WA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ZYMOGENETICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), WA first:
- CORIXA CORP WA
- Seagen Inc. WA
- NS Wind Down Co., Inc. WA
- Adaptive Biotechnologies Corp WA
- Juno Therapeutics, Inc. WA
- LeonaBio, Inc. WA
- Sana Biotechnology, Inc. WA
- Icosavax, Inc. WA
- Intrinsic Medicine, Inc. WA
- Aurion Biotech, Inc. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health